NEWS

Zhejiang Hisun Pharmaceutical gets approval for three drugs to enter clinical trials

Friday, Mar 17, 2017

Zhejiang Hisun Pharmaceutical Co Ltd Says it got approval from China Food and Drug Administration to do clinical trials for three kinds of crud drugs.

The three drugs are used for pulmonary tuberculosis, mammary cancer and hematological malignancies treatment respectively.

 

Source: reuters.com

Other News